Clinical Oncology
Volume 22, Issue 2 , Pages 147-152 , March 2010

Frequency of Screening Magnetic Resonance Imaging to Detect Occult Spinal Cord Compromise and to Prevent Neurological Deficit in Metastatic Castration-resistant Prostate Cancer

  • R. Venkitaraman

      Affiliations

    • Department of Oncology, Ipswich Hospital NHS Trust, Ipswich, UK
    • Corresponding Author InformationAuthor for correspondence: R. Venkitaraman, Ipswich Hospital NHS, Heath Road, Ipswich, Suffolk, IP4 5PD, UK. Tel: +44-1473704177; Fax: +44-1473704916.
    • ,
  • S.A. Sohaib

      Affiliations

    • Division of Radiology, Royal Marsden Hospital, Sutton, Surrey, UK
    • ,
  • Y. Barbachano

      Affiliations

    • Division of Information and Statistics, Royal Marsden Hospital, Sutton, Surrey, UK
    • ,
  • C.C. Parker

      Affiliations

    • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK
    • ,
  • R.A. Huddart

      Affiliations

    • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK
    • ,
  • A. Horwich

      Affiliations

    • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK
    • ,
  • D. Dearnaley

      Affiliations

    • Academic Urology Unit, Royal Marsden Hospital, Sutton, Surrey, UK

Received 9 July 2009 ,Revised 9 November 2009 ,Accepted 10 November 2009.

References 

  1. Rades D, Stalpers LJ, Veninga T, Rudat V, Schulte R, Hoskin PJ. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. J Urol. 2006;175(2):552–556
  2. National Institute for Health and Clinical Excellence (NICE) . Metastatic spinal cord compression: diagnosis and management of patients at risk of or with metastatic spinal cord compression. NICE guideline CG57. NICE; 2008;
  3. Osborn JL, Getzenberg RH, Trump DL. Spinal cord compression in prostate cancer. J Neurooncol. 1995;23(2):135–147
  4. Ruckdeschel JC. Early detection and treatment of spinal cord compression. Oncology (Williston Park). 2005;19(1):81–86discussion 86, 89–92
  5. Kim RY, Spencer SA, Meredith RF, et al. Extradural spinal cord compression: analysis of factors determining functional prognosis – prospective study. Radiology. 1990;176(1):279–282
  6. Rades D, Veninga T, Stalpers LJ, et al. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys. 2006;64(1):182–188
  7. Rades D, Fehlauer F, Schulte R, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol. 2006;24(21):3388–3393
  8. Maranzano E, Trippa F, Chirico L, Basagni ML, Rossi R. Management of metastatic spinal cord compression. Tumori. 2003;89(5):469–475
  9. Tazi H, Manunta A, Rodriguez A, Patard JJ, Lobel B, Guille F. Spinal cord compression in metastatic prostate cancer. Eur Urol. 2003;44(5):527–532
  10. Bayley A, Milosevic M, Blend R, et al. A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer. 2001;92(2):303–310
  11. Venkitaraman R, Sohaib SA, Barbachano Y, et al. Detection of occult spinal cord compression with magnetic resonance imaging of the spine. Clin Oncol (R Coll Radiol). 2007;19(7):528–531
  12. Venkitaraman R, Cook GJ, Dearnaley DP, et al. Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?. Clin Oncol (R Coll Radiol). 2009;21(1):39–42
  13. Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol. 1998;16(4):1613–1624
  14. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys. 1995;32(4):959–967
  15. Venkitaraman R, Barbachano Y, Dearnaley DP, et al. Outcome of early detection and radiotherapy for occult spinal cord compression. Radiother Oncol. 2007;85(3):469–472
  16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  17. Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol). 2003;15(4):211–217
  18. Loblaw DA, Perry J, Chambers A, Laperriere NJ. systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care ontario practice guidelines initiative's neuro-oncology disease site group. J Clin Oncol. 2005;23(9):2028–2037
  19. Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502–1512
  20. Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351(15):1513–1520

PII: S0936-6555(09)00377-X

doi: 10.1016/j.clon.2009.11.007

Clinical Oncology
Volume 22, Issue 2 , Pages 147-152 , March 2010

Article Tools

* Image Usage & Resolution